Harte Hanks to Be Acquired by Star Equity for $5.00/Share in Cash or Preferred Stock
HHS has more than doubled off its 52-week low of $2 on elevated volume (58× avg).
Summary
Harte Hanks agreed to be acquired by Star Equity Holdings for $5.00 per share in cash or preferred stock, a deal valued at approximately $38.4 million, expected to close in Q4 2026.
Key Events · M&A and Partnerships · HHS
-
Definitive Merger Agreement Signed
A merger agreement with Star Equity Holdings was signed on August 14, 2026. Each share of Harte Hanks common stock will be converted into the right to receive either $5.00 in cash or 0.50 shares of Star Equity preferred stock, subject to a 50% cap on aggregate cash consideration.
-
Total Consideration Valued at ~$38.4M
The parties estimate total consideration of approximately 1.92 million shares of Star Equity preferred stock and $19.2 million in cash. At the implied $10.00 per preferred share value, the total deal value is approximately $38.4 million.
-
Financing Structure
Star Equity intends to finance the cash component partly by drawing up to $15 million on its existing revolving credit facility, with the balance from cash on hand.
-
Closing Expected in Q4 2026
The transaction is subject to Harte Hanks stockholder approval and other customary conditions. Closing is expected in the fourth quarter of 2026.
Analysis · HHS · Trade & Services
A definitive merger agreement with Star Equity Holdings was signed on August 14, 2026, setting the stage for a transformative liquidity event. Shareholders will receive either $5.00 per share in cash or 0.50 shares of Star Equity preferred stock, subject to a 50% cap on aggregate cash consideration. The total deal value is approximately $38.4 million (1.92 million preferred shares at $10.00 implied value plus $19.2 million cash). The transaction is expected to close in Q4 2026, pending stockholder approval and other conditions. This provides liquidity to shareholders at a premium to the current stock price of $4.22.
How filings like this one have moved
In the 30 days to Oct 22, 2026, 46.1% of the 284 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.53%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HHS was trading at $4.22 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $31.9M. The 52-week trading range was $2.00 to $4.50. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.